Jagsonpal Pharmaceuticals Limited — Important, 06-12-2024: Updates

The Nomination and Remuneration Committee of Jagsonpal Pharmaceuticals Limited has allocated 31,040 equity shares under the Employee Stock Option Plan, 2022, to eligible employees upon the exercise of vested options. This increases the paid-up share capital from Rs. 13,25,74,610, comprising 2,65,14,922 equity shares, to Rs. 13,27,29,810, with a total of 2,65,45,962 equity shares now issued. The shares issued have an exercise price of Rs. 235 for 23,400 shares and Rs. 284 for 7,640 shares, with respective premiums of Rs. 230 and Rs. 279. This development signals a positive outlook for employee engagement and retention, which can enhance operational performance and align interests with shareholders. Investors should monitor this initiative as it reflects the company's commitment to incentivizing its workforce.